Refine by
Clinical Stage Articles & Analysis: This-Year
1 articles found
Issues such as peptide degradation susceptibility, short half-life, and insufficient immunogenicity limit their widespread clinical use. Therefore, how to improve the stability and immunogenicity of peptide vaccines through innovative technological approaches has become a core topic in the current vaccine development field. ...